Medical Equipment

Point Of Care Lipid Test Market Revenue Expected to Reach $1.16 Billion by 2030 with 9.4% CAGR

March 16, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Point Of Care Lipid Test Market Between 2026 And 2030?

The point of care lipid test market has experienced substantial expansion in recent years. It is forecast to grow from $0.74 billion in 2025 to $0.82 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. This historical growth can be attributed to the increasing prevalence of cardiovascular diseases, the demand for rapid testing, advancements in biosensor technology, a heightened awareness of cholesterol management, and the accessibility of point-of-care devices.

The point of care lipid test market size is projected for substantial expansion in the coming years. By 2030, it is anticipated to reach $1.17 billion, demonstrating a compound annual growth rate (CAGR) of 9.4%. Several factors will drive this growth during the forecast period, including the integration with mobile applications and cloud platforms, increased usage in home care environments, wider adoption in clinics and hospitals, the creation of multi-analyte tests, and partnerships between providers of devices and software. Key developments anticipated for the forecast period encompass fingerstick lipid testing, portable lipid analyzers, multi-parameter analyzers, quicker cardiovascular risk assessments, and lipid monitoring solutions for home use.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28300&type=smp

What Drivers Are Influencing The Point Of Care Lipid Test Market?

The rising incidence of cardiovascular diseases is anticipated to drive the expansion of the point of care lipid test market in the future. These diseases encompass conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and hypertension, frequently stemming from atherosclerosis associated with unusual cholesterol and triglyceride levels. The escalating occurrence of cardiovascular ailments is attributed to increasingly sedentary lifestyles and diminished physical activity, factors that contribute to obesity, compromised circulation, and various other CVD risk factors. Point-of-care lipid tests facilitate the management of the widespread increase in cardiovascular diseases by offering rapid, immediate measurements of cholesterol and other lipid levels, thereby allowing for early risk detection and timely treatment choices to hinder disease advancement. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that fatalities from cardiovascular disease reached 931,578, marking a rise of 3,000 deaths compared to the previous year’s figure of 928,741. Consequently, the expanding occurrence of cardiovascular diseases is projected to drive the development of the point of care lipid test market.

Which Market Segments Are Examined In The Point Of Care Lipid Test Market Study?

The point of care lipid test market covered in this report is segmented –

1) By Product Types: Instruments, Consumables

2) By Application: Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications

3) By End-User: Hospitals, Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Instruments: Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers

2) By Consumables: Test Strip, Reagents And Kits

Which Trends Are Influencing The Point Of Care Lipid Test Market?

Leading companies in the point-of-care lipid test market are prioritizing innovative approaches, such as advanced point-of-care (POC) diagnostic platforms, to provide rapid, accurate, and lab-quality lipid panel results at the patient’s location, thereby enhancing clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform is defined as a portable, integrated device that performs quick, precise, and lab-grade tests close to the patient, enabling real-time medical judgments and prompt health interventions. For example, in July 2023, Vital Biosciences Inc., a Canada-based health technology company, introduced a point-of-care lab testing platform called VitalOne. This system is designed to deliver over 50 lab-grade blood test results within just 20 minutes, using a compact, automated device in settings such as clinics and pharmacies. VitalOne combines hematology, clinical chemistry, and immunoassays into a single instrument, empowering healthcare providers to perform testing, diagnosis, and treatment during a single visit. This radically improves the accessibility, speed, and personalized nature of patient care, while maintaining accuracy comparable to traditional central labs.

Who Are The Primary Competitors In The Point Of Care Lipid Test Market?

Major companies operating in the point of care lipid test market are Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., Nova Biomedical Corporation

Read the full point of care lipid test market report here:

https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Point Of Care Lipid Test Market?

North America was the largest region in the point of care lipid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care lipid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Point Of Care Lipid Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28300&type=smp

Browse Through More Reports Similar to the Global Point Of Care Lipid Test Market 2026, By The Business Research Company

Low Density Lipoprotein Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Lipid Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Cholesterol Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795